ONCONOVA THERAPEUTICS, INC. Common Stock ($0.01 par value per share) Sales AgreementSales Agreement • May 17th, 2019 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2019 Company Industry JurisdictionOnconova Therapeutics, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows: